Analysts Set $37.67 Price Target for Establishment Labs Holdings Inc (ESTA)

Establishment Labs Holdings Inc (NASDAQ:ESTA) has earned an average broker rating score of 1.00 (Strong Buy) from the three brokers that provide coverage for the stock, Zacks Investment Research reports. Three research analysts have rated the stock with a strong buy rating.

Analysts have set a 12 month consensus price objective of $37.67 for the company and are anticipating that the company will post ($0.40) earnings per share for the current quarter, according to Zacks. Zacks has also given Establishment Labs an industry rank of 101 out of 255 based on the ratings given to its competitors.

Separately, BTIG Research reiterated a “buy” rating and set a $40.00 price objective on shares of Establishment Labs in a research note on Monday, March 25th.

Shares of NASDAQ:ESTA opened at $24.04 on Friday. The firm has a market cap of $519.92 million and a price-to-earnings ratio of -21.46. Establishment Labs has a 12-month low of $20.05 and a 12-month high of $30.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 6.05 and a quick ratio of 4.54.

Establishment Labs (NASDAQ:ESTA) last announced its quarterly earnings data on Wednesday, March 20th. The company reported ($0.51) earnings per share (EPS) for the quarter. The company had revenue of $16.40 million for the quarter, compared to analysts’ expectations of $14.70 million. Establishment Labs had a negative net margin of 34.47% and a negative return on equity of 90.07%. As a group, research analysts anticipate that Establishment Labs will post -1.58 EPS for the current year.

A number of large investors have recently made changes to their positions in the business. Kornitzer Capital Management Inc. KS purchased a new position in Establishment Labs during the third quarter valued at $361,000. Marshall Wace North America L.P. purchased a new position in Establishment Labs during the third quarter valued at $407,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in Establishment Labs during the third quarter valued at $954,000. Point72 Asset Management L.P. purchased a new position in Establishment Labs during the third quarter valued at $1,025,000. Finally, Sio Capital Management LLC purchased a new position in Establishment Labs during the third quarter valued at $1,077,000. Institutional investors and hedge funds own 22.97% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name.

Read More: What is a Candlestick Chart?

Get a free copy of the Zacks research report on Establishment Labs (ESTA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.